(Q35987756)

11 August 2017

1 reference

title

Treatment of muscle-invasive bladder cancer: progress and new challenges (English)

1 reference

11 August 2017

1 reference

Judi C Herring

1

1 reference

PubMed ID

15606332

11 August 2017

Ashish M Kamat

series ordinal

2

1 reference

11 August 2017

1 December 2004

1 reference

Expert Review of Anticancer Therapy

11 August 2017

1 reference

11 August 2017

4

1 reference

11 August 2017

1047-1056

1 reference

11 August 2017

6

1 reference

Effect of routine repeat transurethral resection for superficial bladder cancer: a long-term observational study.

11 August 2017

1 reference

https://api.crossref.org/works/10.1586%2F14737140.4.6.1047

Bladder cancer: analysis of multi-detector row helical CT enhancement pattern and accuracy in tumor detection and perivesical staging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.4.6.1047

Evidence supporting preoperative chemotherapy for small cell carcinoma of the bladder: a retrospective review of the M. D. Anderson cancer experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.4.6.1047

Nodal involvement in bladder cancer cases treated with radical cystectomy: incidence and prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.4.6.1047

Radical cystectomy for bladder cancer today--a homogeneous series without neoadjuvant therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.4.6.1047

Neoadjuvant chemotherapy with cisplatin and methotrexate in patients with muscle-invasive bladder tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.4.6.1047

Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.4.6.1047

Neoadjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.4.6.1047

Neoadjuvant cisplatinum based combination chemotherapy in patients with invasive bladder cancer: a combined analysis of two Nordic studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.4.6.1047

Systemic chemotherapy for patients with bladder cancer--current controversies and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.4.6.1047

The role of adjuvant combination chemotherapy after cystectomy in locally advanced bladder cancer: what we do not know and why.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.4.6.1047

The health economics of bladder cancer: a comprehensive review of the published literature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.4.6.1047

Economic evaluation in a randomized phase III clinical trial comparing gemcitabine/cisplatin and etoposide/cisplatin in non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.4.6.1047

p53 and p21 Expression levels predict organ preservation and survival in invasive bladder carcinoma treated with a combined-modality approach.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.4.6.1047

Chemotherapy and cystectomy for invasive transitional cell carcinoma of bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.4.6.1047

21 January 2018

Focus on bladder cancer

1 reference

https://api.crossref.org/works/10.1586%2F14737140.4.6.1047

10.1586/14737140.4.6.1047

21 January 2018

Identifiers

DOI

1 reference

11 August 2017

1 reference

PubMed ID

15606332